15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200
Sign in 0

NAD+ 500mg

$39.99 or subscribe for $33.99/mo

Lot PL-2609-067 tested in our lab: 99.88% purity by HPLC Certificate PL-26-00067, analysed Sep 19, 2026 · LC-MS identity, endotoxin and sterility on the certificate · details and COA images
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Safety data sheet PL-SDS-114 GHS: not classified as hazardous · Read the SDS · PDF

Visa, Mastercard, Discover up to $1,000 per order (charged in MXN; your bank may add a foreign-transaction fee). Pay by Bank, Zelle, Cash App or crypto: 10% off.

NAD+ 500 mg: oxidized nicotinamide adenine dinucleotide free acid, a dinucleotide coenzyme and not a peptide, as dry powder in a sealed vial. Each lot is tested in PrymaLab’s own laboratory and has its own certificate. Research use only.

Description

PrymaLab · Research use only

NAD+ 500mg

NAD+ free acid, 500 mg of dry powder, the smaller of the two vial fills

NAD+ is nicotinamide adenine dinucleotide in its oxidized form, a coenzyme built from two nucleotides and not a peptide. This vial holds 500 mg of the free acid as a white powder, half the main fill. Published work on NAD+ looks at how cells use it to move electrons, how sirtuins and PARPs consume it, and why its level drops with age in animal studies.

Specifications

NAD+ 500mg at a glance
Property Value
Compound NAD+ β-Nicotinamide adenine dinucleotide, oxidized (free acid); coenzyme, not a peptide
CAS number 53-84-9
Molecular formula C21H27N7O14P2
Theoretical mass 663.4 Da
Sequence / structure Dinucleotide: adenosine 5′-monophosphate joined through a pyrophosphate bridge to nicotinamide 5′-mononucleotide; oxidized form.
Label claim 500 mg/vial
Form Crystalline or amorphous powder in a sealed glass vial
Storage, sealed −20 °C, tightly sealed, dry, dark
Purity specification 99.0% or higher by RP-HPLC
Lot certificate Results for the lot now shipping are in the certificate panel on this page
Safety data sheet PL-SDS-114

Other fills

This is the 500 mg fill. The NAD+ 1000mg page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 1000 mg.

What the research covers

Rajman and colleagues called NAD the cell’s hydrogen carrier for redox enzymes and described its newer role as a signal, with NAD+-sensing enzymes governing processes from energy metabolism to cell survival1. They reported that NAD+ declines steadily with age and that restoring it promoted health and extended lifespan in old or diseased animals1. Much of that restoring was done with the precursors NMN and NR, whose translation to people was still to be tested in 20182. The NAD+ 1000 mg vial page has the full research summary.

The NAD+ Peptide guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

Is this the same NAD+ as the 1,000 mg vial?

Yes. Both hold oxidized NAD+ as the free acid, CAS 53-84-9, with a theoretical mass of 663.4 Da. The 500 mg fill is a separate lot, so it carries its own lot number and certificate, shown in the panel on this page.

What is 500 mg in molar terms?

About 754 µmol, using the certificate's theoretical mass of 663.4 Da. The real figure is slightly lower because the powder holds a little residual water, which the certificate reports as a percentage.

How should the vial be kept?

Sealed at −20 °C, dry and away from light, which is the storage line on the certificate. Let it warm up before the seal is broken. Solutions belong in the refrigerator, shielded from light, for no longer than your laboratory has shown to be acceptable.

References

  1. Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529-547. DOI · PubMed
  2. Yoshino J, Baur JA, Imai SI. NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513-528. DOI · PubMed

Research use only

For laboratory research use only. NAD+ 500mg is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of NAD

NAD is also stocked as NAD+ Nasal Spray, NAD+ (injectable) 500mg/ml preloaded 3ml pen and NAD+ 100mg/ml preloaded 3ml pen. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.

Additional information

Weight N/A
Dimensions N/A

Lot PL-2609-067 · Certificate of Analysis PL-26-00067

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

CompoundNAD+
β-Nicotinamide adenine dinucleotide, oxidized (free acid); coenzyme, not a peptide
CAS number53-84-9
Molecular formulaC21H27N7O14P2
Theoretical mass663.4 Da
Sequence / structureDinucleotide: adenosine 5′-monophosphate joined through a pyrophosphate bridge to nicotinamide 5′-mononucleotide; oxidized form.
AppearanceWhite powder
Storage−20 °C, tightly sealed, dry, dark
Label claim500 mg/vial
Lot numberPL-2609-067
Certificate numberPL-26-00067
Date of analysis2026-09-19 (retest 2028-09-18)
Purity (RP-HPLC)99.88%
Identity (LC-MS)663.6 Da
Water content (KF)2.6%
Endotoxin (LAL)0.04 EU/mg
SterilityNo growth; conforms
ConclusionPASS
Tested byPrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Certificate of analysis for lot PL-2609-067, page 1
Certificate page 1: results
Certificate of analysis for lot PL-2609-067, page 2
Certificate page 2: method and approval

Safety data sheet PL-SDS-114 · NAD+

GHS safety data sheet for this product (powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Not classified as hazardous Not classified under OSHA HCS 2012 / GHS. No pictogram, signal word or hazard statement is required; handle as a pharmacologically active laboratory chemical.
CompositionNAD+ (CAS 53-84-9) · ≥ 95% (dry basis, as supplied), 500 mg, 1000 mg per vial
ClassificationNot classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Physical stateSolid. White to off-white powder (hygroscopic).
StorageSealed, cool and dry (2–8 °C recommended), protected from light and moisture
HandlingAvoid generating or inhaling dust; weigh inside a ventilated enclosure. Hygroscopic materials should be weighed quickly and the vial resealed. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

NAD+ article cover image

NAD+ Peptide: What It Is and What the Research Shows

NAD+ is a coenzyme, not a peptide, present in every living cell. This guide covers its chemistry, its role in energy metabolism and DNA repair enzymes, and what research on NAD+ and its precursors has measured.

Infographic: NAD+ Peptide Delivery Routes Compared: Shots, IV, Nasal, Patches and Oral Precursors

NAD Shots vs IV vs Nasal vs Oral Precursors: Routes Compared

There is a step in NAD+ biology that decides this entire debate, and it happens after delivery and before anything useful occurs. NAD+ does not cross the plasma membrane. Whatever route puts it in the body, it gets taken apart at the cell surface and rebuilt inside.

Glutathione research library featured image: the tripeptide has a fourteen-minute plasma half-life after intravenous dosing, no pharmacokinetic data for injected shots, an unblinded negative skin-lightening trial, and a 2026 endotoxin cluster that the FDA traced to one supplement-grade lot

Glutathione by Route: Intravenous, Nasal and Oral Pharmacokinetics, the Skin-Lightening Trial Nobody Blinded, and the 2026 Endotoxin Recalls

Glutathione’s plasma half-life after an intravenous dose is fourteen minutes, a 3 g oral dose does not move plasma levels, and the only controlled trial of injected glutathione for skin lightening was unblinded and negative. This reference goes route by route through what each has actually been shown to do, and through the 2026 endotoxin cluster in which the FDA traced thirty-odd adverse reactions to one supplement-grade lot.

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

7-day returns on unopened, sealed products, plus our third-party testing guarantee.

Shipping truck icon
Free US shipping

Free USA shipping over $100 and free worldwide shipping over $200.

RealReviews.io Rate your experience with PrymaLab